Racial differences in T-lymphocyte response to glucocorticoids.

BACKGROUND Asthma morbidity and mortality is increased in blacks. OBJECTIVE The primary objective of this cross-sectional study was to determine if blacks, asthmatic or nonasthmatic, displayed diminished T-lymphocyte response to glucocorticoids in vitro compared to their white counterparts. If differences were noted, this would suggest a racial predisposition to decreased glucocorticoid responsiveness among blacks. METHODS Asthmatic (n = 395, 27% blacks) and control (n = 202, 52% blacks) subjects recruited from National Jewish Medical and Research Center and from the surrounding community participated in the study. In vitro glucocorticoid responsiveness was determined by assessing the log-transformed concentration of dexamethasone required to suppress phytohemagglutinin-induced T-lymphocyte proliferation by 50% (log(10) IC(50)). Asthma medication history, atopic status, and spirometric lung function measures corrected for race were collected. RESULTS Black and white asthmatic subjects had similar FEV(1) percentage of predicted values and inhaled and oral glucocorticoid requirements. Black asthmatic subjects displayed significantly diminished glucocorticoid responsiveness compared to white asthmatic subjects, as follows: median (first, third quartile) log(10) IC(50) values of 1.00 nmol (0.48, 1.83) vs 0.78 nmol (0.29, 1.45) [p = 0.028]. Similar results were found between black and white control subjects, as follows: median, 1.26 nmol (0.70, 2.14) vs 0.95 nmol (0.55, 1.48) [p = 0.01]. Age, race, and basal T-lymphocyte activity were significantly positively correlated to the log(10) IC(50) values. CONCLUSION Our observation that black asthmatic subjects and non-asthmatic control subjects require greater concentrations of glucocorticoid in vitro to suppress T-lymphocyte activation suggests that blacks have a racial predisposition to diminished glucocorticoid responsiveness, which may contribute to their heightened asthma morbidity.

[1]  A. Kay,et al.  The role of T lymphocytes in the pathogenesis of asthma. , 2003, The Journal of allergy and clinical immunology.

[2]  J. Bloom,et al.  Update on glucocorticoid action and resistance. , 2003, The Journal of allergy and clinical immunology.

[3]  L. Akinbami,et al.  Trends in childhood asthma: prevalence, health care utilization, and mortality. , 2002, Pediatrics.

[4]  D. Hricik,et al.  Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids , 2002, Transplantation.

[5]  Stephen C Lazarus,et al.  Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .

[6]  D. Harlan,et al.  Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. , 2001, Transplantation.

[7]  J. Burdick,et al.  Decreased effect of immunosuppression on immunocompetence in African–Americans after kidney and liver transplantation , 2001, Clinical transplantation.

[8]  C. C. Johnson,et al.  Racial differences in physiologic parameters related to asthma among middle-class children. , 2000, Chest.

[9]  K. Weiss,et al.  The relation of socioeconomic factors and racial/ethnic differences in US asthma mortality. , 2000, American journal of public health.

[10]  C. Dayan,et al.  Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. , 1999, The Journal of clinical endocrinology and metabolism.

[11]  Xin Qun Wang,et al.  Racial disparities in renal transplant outcomes. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  E. Silverman,et al.  Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. , 1999, American journal of respiratory and critical care medicine.

[13]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[14]  S. Szefler,et al.  Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. , 1998, The Journal of allergy and clinical immunology.

[15]  S. Durham,et al.  Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. , 1997, Journal of immunology.

[16]  S. Szefler,et al.  Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. , 1997, American journal of respiratory and critical care medicine.

[17]  S. Szefler,et al.  Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma. , 1996, The Journal of allergy and clinical immunology.

[18]  S. Durham,et al.  IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. , 1996, American journal of respiratory and critical care medicine.

[19]  C. Corrigan,et al.  Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. , 1996, The European respiratory journal.

[20]  I. Adcock,et al.  Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[21]  R. Martin,et al.  Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[22]  J. Virchow,et al.  Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. , 1992, The American review of respiratory disease.

[23]  S. Szefler,et al.  Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. , 1991, The American review of respiratory disease.

[24]  P. Kimball,et al.  Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. , 1991, Transplantation.